| Literature DB >> 31462001 |
Soon Seok Kim1, Jin Ah Lee1, Min-Kyeong Yeo2.
Abstract
Hydra magnipapillata cells reduce the toxicity of silver nanomaterials to zebrafish (Danio rerio) embryos. In this study, we investigated whether Hydra protein (HP) and Hydra basal disc peptide (Hym176) materials reduce nano-Ag-polyvinylpyrrolidone (N-Ag-PVP) toxicity during embryogenesis of the nanosensitive organism zebrafish. Protein (HP) was extracted from Hydra, and peptide (Hym176) was extracted from the hydra basal disc, which is attractive to nanomaterials and related to the immune system. The experimental conditions were exposure to N-Ag-PVP, HP, N-Ag-PVP+HP, Hym176, or N-Ag-PVP+Hym176 during embryo development. N-Ag-PVP+HP group showed lower toxicity than N-Ag-PVP group. In addition, in the N-Ag-PVP+HP group formed aggregated nanomaterials (≥200 nm size) through electrostatic bonding. In the gene expression profile, HP group differed in gene expression profile compared the other experimental groups and it was no genetic toxicity. HP showed a tendency to reduce side effects and abnormal gene expression produced by N-Ag-PVP with no evidence of inherent toxicity. Considering the potential nanotoxicity effects of released nanomaterials on the ecosystem, the reduction of nanotoxicity observed with HP natural materials should be regarded with great interest in terms of the overall health of the ecosystem.Entities:
Keywords: Hydra peptide; Hydra protein; microarray; nano-Ag-polyvinylpyrrolidone; nanotoxicity; reduced toxicity
Year: 2019 PMID: 31462001 PMCID: PMC6780337 DOI: 10.3390/nano9091210
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Primer of key genes involved in the signaling pathway selected for qRT-PCR.
| Gene Name | Gene Symbol | Function | Accession No. | Primer Sequences (5′ → 3′) |
|---|---|---|---|---|
| claudin a | cldna | structural molecule activity | NM | (F) TGTGGCAAGTCACTGCTTTT |
| cell division cycle 42, like | cdc42l | GTP binding, GTPase activity, nucleotide binding, protein kinase binding | NM | (F) GGCAGGAAGACTACGACAGA |
| insulin-like growth factor 1 | igf1 | Growth factor activity, hormone activity, insulin-like growth factor receptor binding | NM | (F) GTGGACGAATGCTGCTTTCA |
| zgc:55558 | zgc:55558 | GTP binding, GTPase activity, nucleotide binding, | NM | (F) TTTTTACACCCCCATCCTTT |
| mitogen-activated protein kinase 10 | mapk10 | ATP binding, JUN kinase activity, MAP kinase activity, kinase activity, nucleotide binding, protein kinase activity, protein serine/threonine kinase activity, transferase activity | NM | (F) TCGAGGAGAGAACAAAGAATGG |
| mitogen-activated protein kinase 11 | mapk11 | ATP binding, MAP kinase activity, kinase activity, nucleotide binding, protein kinase activity, protein serine/threonine kinase activity, transferase activity | NM | (F) CAGTACTGCCCTCTCCTTCTT |
| tumor protein p53 | tp53 | DNA binding, DNA-binding transcription factor activity, metal ion binding, promoter-specific chromatin binding, protein binding, sequence-specific DNA binding, transcription regulatory region DNA binding, | NM | (F) TGCGATACATGTGATCCATT |
| actin, beta 2 | actb2 | ATP binding, nucleotide binding | NM | (F) GACTCAAACTGCGCAGAGAA |
Analyses of zeta potential and DLS changes of N-Ag-PVP and N-Ag-PVP + HP.
| N-Ag-PVP | N-Ag-PVP+HP | |
|---|---|---|
| Zeta potential (mV) | −22.84 ± 0.16 | −5.54 ± 0.80 |
| Diameter (nm) | 285.50 ± 16.40 | 534.40 ± 122.05 |
Figure 1The effects of N-Ag-PVP, HP, N-Ag-PVP+HP, Hym176, and N-Ag-PVP+Hym176 on the hatching and abnormal rate (a) and rates of specific abnormal morphologies among surviving embryos (b). All measurements are reported as the group mean of three replicates and the standard deviation (n = 60). * comparison of experimental groups to a homogeneous subset of post-hoc test results (p < 0.05), ** comparison of experimental groups to a homogeneous subset of post-hoc test results (p < 0.01).
Figure 2Venn diagrams illustrating the gene expression patterns in each experimental group; contra-regulated means that the effects on gene expression are opposite to each other (Fold change: ≥2, ≤0.5; Normalized RC (log2): ≥10). (a)Ag-PVP/control vs HP/control vs Ag-PVP+HP/control, (b)Ag-PVP/control vs Hym176/control vs Ag-PVP+Hym176/control, (c)Ag-PVP/control vs HP/control vs Hym176/control, (d)Ag-PVP/control vs Ag-PVP+HP/control vs Ag-PVP+ Hym176/control, (e)Ag-PVP+HP/control vs HP/control vs Hym176/control vs Ag-PVP+ Hym176/control.
Comparison of the number of genes with differences in expression level.
| Total Genes | Up-Regulated | Down-Regulated | ||
|---|---|---|---|---|
| N-Ag-PVP | vs. Control | 957 (6.61%) | 377 | 580 |
| HP | vs. Control | 2686 (18.56%) | 1066 | 1620 |
| N-Ag-PVP+HP | vs. Control | 928 (6.41%) | 379 | 549 |
| Hym176 | vs. Control | 1229 (8.49%) | 545 | 684 |
| N-Ag-PVP+Hym176 | vs. Control | 1284 (8.87%) | 632 | 652 |
| N-Ag-PVP+HP | vs. HP | 2879 (19.89%) | 1652 | 1227 |
| N-Ag-PVP+Hym176 | vs. Hym176 | 164 (1.13%) | 112 | 52 |
| N-Ag-PVP+Hym176 | vs. N-Ag-PVP+HP | 353 (2.44%) | 202 | 151 |
| N-Ag-PVP+HP | vs. N-Ag-PVP | 110 (0.76%) | 49 | 61 |
| N-Ag-PVP+Hym176 | vs. N-Ag-PVP | 552 (3.81%) | 332 | 220 |
Genes showing toxicity reduction effects classified according to GO of morphogenesis.
| Gene Description | Gene Symbol | Regulation Profile and Ratio(Fold change) | ||||
|---|---|---|---|---|---|---|
| N-Ag-PVP | HP | N-Ag-PVP+HP | Hym176 | N-Ag-PVP | ||
|
| ||||||
| LIM domain 7b | lmo7b | 2.708 | 0.743 | 1.415 | 2.264 | 1.425 |
| fibronectin 1b | fn1b | 2.179 | 1.643 | 1.723 | 3.874 | 5.859 |
| myosin binding protein C, cardiac | mybpc3 | 0.357 | 1.706 | 0.569 | 0.493 | 0.959 |
|
| ||||||
| Sec23 homolog A, COPII coat complex component | sec23a | 0.448 | 1.369 | 0.709 | 0.588 | 0.832 |
| procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1a | plod1a | 0.441 | 0.869 | 0.611 | 0.462 | 0.665 |
|
| ||||||
| LIM domain 7b | lmo7b | 2.708 | 0.743 | 1.415 | 2.264 | 1.425 |
| lumican | lum | 0.491 | 1.359 | 0.620 | 0.701 | 0.625 |
| Sec23 homolog A, COPII coat complex component | sec23a | 0.448 | 1.369 | 0.709 | 0.588 | 0.832 |
|
| ||||||
| intraflagellar transport 80 homolog (Chlamydomonas) | ift80 | 2.179 | 0.722 | 1.356 | 1.416 | 1.203 |
| tubulin, gamma complex associated protein 4 | tubgcp4 | 2.017 | 0.698 | 1.563 | 1.177 | 0.896 |
| lumican | lum | 0.491 | 1.359 | 0.620 | 0.701 | 0.625 |
| adiponectin receptor 1b | adipor1b | 0.444 | 0.924 | 0.620 | 0.271 | 0.371 |
Figure 3(a) Pathway for effects on cell cycle regulation and intercellular signaling in zebrafish exposed to N-Ag-PVP; and heat maps of the (b) tight junction, (c) fork headbox O (FOXO) signaling pathway, and (d) mitogen-activated protein kinases (MAPK) signal pathway. (b–d) show the z-scores based on the average of each expressed gene.
Figure 4(a) Effects of N-Ag-PVP exposure on G-protein-coupled receptor (GPCR) gene expression in zebrafish larvae and (b) heatmap of GPCRs by z-score. N-Ag-PVP stimulated up-regulation of several GPCR genes. The z-score is based on the average of each expressed gene.
Figure 5Comparison of expected and measured expression of key genes in zebrafish larvae exposed to N-Ag-PVP, HP, N-Ag-PVP+HP, Hym176, or N-Ag-PVP+Hym176. (a) Gene expression level by z-score and (b) relative target RNA level (2−ΔΔCt). The z-score is based on the average of each expressed gene (ΔCt = Target Ct − actb2 Ct, ΔΔCt = Target Sample ΔCt − control Sample ΔCt, 2−ΔΔCt = Normalized gene amount of target group relative to target gene amount of control group).